<?xml version="1.0" encoding="UTF-8"?>
<table-wrap id="Tab2">
 <label>Table 2</label>
 <caption>
  <p>Current suggested drugs in COVID-19 treatment
   <sup>a</sup>.
  </p>
 </caption>
 <table frame="hsides" rules="groups">
  <thead>
   <tr>
    <th>Drug</th>
    <th colspan="2">Dosage (For adult)</th>
    <th>Route of administration</th>
    <th colspan="2">Course of treatment</th>
   </tr>
  </thead>
  <tbody>
   <tr>
    <td>IFN-α</td>
    <td>5,000,000 U</td>
    <td>Twice daily</td>
    <td>Aerosol inhalation</td>
    <td/>
    <td/>
   </tr>
   <tr>
    <td>Lopinavir/ritonavir</td>
    <td>400 mg/100 mg</td>
    <td>Twice daily</td>
    <td>Oral</td>
    <td>≤10 days</td>
    <td/>
   </tr>
   <tr>
    <td>Ribavirin</td>
    <td>500 mg</td>
    <td>2–3 times daily</td>
    <td>Intravenous injection</td>
    <td>≤10 days</td>
    <td>Combination with interferon or lopinavir /ritonavir recommended</td>
   </tr>
   <tr>
    <td>Chloroquine phosphate</td>
    <td>500 mg</td>
    <td>Twice daily</td>
    <td>Oral</td>
    <td>7 days</td>
    <td>18–65 years old, weight 50 kg</td>
   </tr>
   <tr>
    <td>Chloroquine phosphate</td>
    <td>500 mg</td>
    <td>Day 1–2 twice daily; Day 3–7 once daily</td>
    <td>Oral</td>
    <td>7 days</td>
    <td>18–65 years old, weight &lt;50 kg</td>
   </tr>
   <tr>
    <td>Arbidol</td>
    <td>200 mg</td>
    <td>Three times daily</td>
    <td>Oral</td>
    <td>≤10 days</td>
    <td/>
   </tr>
  </tbody>
 </table>
 <table-wrap-foot>
  <p>
   <sup>a</sup>According to the 7th trial version of “Diagnosis and Treatment Protocol for Novel Coronavirus Pneumonia”.
  </p>
 </table-wrap-foot>
</table-wrap>
